Filing Details

Accession Number:
0001179110-14-000786
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-01-09 19:13:39
Reporting Period:
2014-01-08
Filing Date:
2014-01-09
Accepted Time:
2014-01-09 19:13:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
792977 Amag Pharmaceuticals Inc. AMAG Pharmaceutical Preparations (2834) 042742593
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1537668 G Christopher White 1100 Winter Street
Waltham MA 02451
Chief Business Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-01-08 2,000 $23.91 26,834 No 4 S Direct
Common Stock Disposition 2014-01-09 1,700 $20.61 25,134 No 4 S Direct
Common Stock Disposition 2014-01-09 100 $21.40 25,034 No 4 S Direct
Common Stock Disposition 2014-01-09 200 $22.41 24,834 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The shares reported on this Form 4 were effected pursuant to a 10b5-1 plan adopted by the reporting person.
  2. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $23.77 - $24.07. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
  3. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $20.12 - $21.00. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.
  4. The shares sold on this date were sold in multiple transactions. The price reflected is the weighted average sales price per share of all shares sold under this reporting event on this date. The actual sales prices per share range from $22.40 - $22.41. Upon request by the Securities and Exchange Commission, AMAG Pharmaceuticals, Inc., or any security holder of the Issuer, the reporting person will provide full information regarding the number of shares sold at each price.